Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Pulawy – page 8

833 clinical trials in Pulawy, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Pulawy at a glance
833
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

833 trials in Pulawy

Open in trial search

Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Adenosine
  • Sponsor:Syn2bio S.A.

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Schizophrenia

Recruiting

Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Vafidemstat
  • Sponsor:Oryzon Genomics S.A.

Efficacy and safety of gadopiclenol versus gadoteric acid‑enhanced MRA in adult patients with suspected vascular disease

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Gadopiclenol
  • Sponsor:Bracco Imaging S.p.A.

B-cell lymphoma

Recruiting

A study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting

Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Bortezomib
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Cardiac failure

Recruiting

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

First-line treatment of metastatic non‑small cell lung cancer with high PD‑L1 expression: ivonescimab versus pembrolizumab

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ivonescimab
  • Sponsor:Summit Therapeutics Inc.

Alopecia areata

Recruiting

Study of ritlecitinib tosilate for hair regrowth in adults and adolescents (12 years and older) with moderate alopecia areata

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Zenagamtide versus semaglutide: a study of blood sugar and weight reduction in adults with type 2 diabetes inadequately controlled on metformin and/or SGLT2 inhibitor

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Pulawy

What the registry says about research in the country

01 Respiratory Health Research

Innovative clinical trials focusing on respiratory viral infections in older adults, including studies of novel vaccines against RSV and human metapneumovirus. Additional research examines influenza prevention strategies using adjuvanted vaccines.

  • RSV and hMPV Prevention
  • Influenza Protection
  • Vaccine Co-administration Studies

These trials aim to enhance protection for adults aged 60 and older against common respiratory infections.

02 Metabolic Disorders

Comprehensive research into obesity and type 2 diabetes management, evaluating new therapeutic approaches for weight management and glycemic control. Studies include both standalone obesity treatments and combined approaches for diabetes management.

  • Weight Management Therapies
  • Diabetes Control
  • Combined Treatment Approaches

Trials focus on developing effective treatments for metabolic conditions affecting quality of life.

03 Cardiovascular Research

Advanced studies in cardiovascular health, investigating treatments for acute myocardial infarction, atrial fibrillation, and chronic heart failure. Research includes novel approaches to prevent strokes and manage various heart conditions.

  • Heart Attack Treatment
  • Stroke Prevention
  • Heart Failure Management

These trials aim to improve outcomes for patients with various cardiac conditions.

04 Dermatological Studies

Research focusing on psoriasis treatment, evaluating new oral medications for mild-to-moderate cases. Studies aim to determine optimal dosing and efficacy of novel therapeutic approaches.

  • Psoriasis Treatment
  • Oral Medication Studies
  • Dose Optimization

Trials are designed to advance treatment options for common skin conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.